Graf Akcie AUPH (Aurinia Pharmaceuticals Inc). Diskuze k akciím AUPH. Aktuální informace AUPH.

Základní informace o společnosti Aurinia Pharmaceuticals Inc (Akcie AUPH)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.63B
Hodnota podniku (EV) N/A
Tržby N/A
EBITDA N/A
Zisk -147.59
Růst v tržbách Q/Q 2,946.67 %
Růst v tržbách Y/Y 15,938.36 %
P/E (Cena vůči ziskům) 0.00
Forward P/E N/A
EV/Sales 40.28
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 44.87
P/FCF N/A
Price/Book 6.45
Účetní hodnota na akcii 3.26
Hotovost na akcii 3.19
FCF vůči ceně -4.57 %
Počet zaměstnanců 294
Tržba na zaměstnance 173.476k
Profit margin -204.88 %
Operating margin -257.05 %
Gross margin -0.42 %
EBIT margin -254.04 %
EBITDA margin -63,847.86 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst N/A %
EPS - Očekávaný růst příští rok -36.36 %
Return on assets -27.15 %
Return on equity -51.67 %
ROIC -26.45 %
ROCE -32.72 %
Dluhy/Equity 0.14
Čistý dluh/EBITDA N/A
Current ratio 11.93
Quick Ratio 11.02
Volatilita 7.19
Beta 0.39
RSI 53.67
Cílová cena analytiků 23
Známka akcie (dle analytiků) 1.11
Insider ownership 8.02 %
Institutional ownership 46.85 %
Počet akcií 128.396M
Procento shortovaných akcií 14.26 %
Short ratio 4.39 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2009
Země Canada

Finanční výsledky akcie AUPH

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$0.318$0.463$0.418$0.173$0.235$0.278$0.981
Cost Of Goods Sold-------
Gross Profit$0.318$0.463$0.418$0.173$0.235$0.278$0.981
Research And Development Expenses$52.866$41.382$33.93$14.534$15.982$9.112-
SG&A Expenses$22.154$13.674$12.096$6.974$6.275$6.927-
Other Operating Income Or Expenses-------
Operating Expenses$76.568$56.621$47.482$22.987$23.815$18.628-
Operating Income$-76.25$-56.158$-47.064$-22.814$-23.58$-18.35$0.981
Total Non-Operating Income/Expense$-47.452$-7.889$-23.728$-0.481$4.973$-1.071-
Pre-Tax Income$-123.702$-64.047$-70.792$-23.295$-18.607$-19.421$0.981
Income Taxes$0.144$0.073-----
Income After Taxes$-123.846$-64.12$-70.792$-23.295$-18.607$-19.421$0.981
Other Income-------
Income From Continuous Operations$-123.846$-64.12$-70.792$-23.295$-18.607$-19.421$-4.302
Income From Discontinued Operations-------
Net Income$-123.846$-64.12$-70.792$-23.295$-18.607$-19.421$-2.632
EBITDA$-74.82$-54.711$-45.726$-21.503$-22.24$-17.047$0.981
EBIT$-76.25$-56.158$-47.064$-22.814$-23.58$-18.35$0.981
Basic Shares Outstanding9385773532296
Shares Outstanding9385773532296
Basic EPS$-1.33$-0.76$-0.92$-0.66$-0.58$-0.67$-0.42
EPS - Earnings Per Share$-1.33$-0.76$-0.92$-0.66$-0.58$-0.67$-0.42
# 2020 2019 2018 2017 2016 2015
Current Ratio27.900618.296121.50335.2234.571211.8304
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin100100100100100100
Operating Margin-23977.99-12129.16-11259.33-13187.28-10034.04-6600.72
EBIT Margin-23977.99-12129.16-11259.33-13187.28-10034.04-6600.72
EBITDA Margin-23528.3-11816.63-10939.23-12429.48-9463.83-6132.016
Pre-Tax Profit Margin-38900-13833.04-16935.88-13465.32-7917.873-6985.971
Net Profit Margin-38945.29-13848.81-16935.88-13465.32-7917.873-6985.971
Asset Turnover0.0010.00320.00220.0030.0070.0053
Inventory Turnover Ratio------
Receiveable Turnover0.86412.13363.83492.011653.0217
Days Sales In Receivables422.39171.069195.1794181.445173120.7914
ROE - Return On Equity-45.2793-56.9576-42.7119-64.7983-93.2074-57.3381
Return On Tangible Equity-47.2204-64.1463-46.6883-114.1912-627.3429-126.258
ROA - Return On Assets-37.9101-43.9591-37.289-40.8706-55.4324-37.0785
ROI - Return On Investment-45.2793-56.9576-42.7119-64.7983-93.2074-57.3381
Book Value Per Share2.44651.31671.97190.68080.61831.0645
Operating Cash Flow Per Share-0.0734-0.0735-0.00490.02220.0308-0.5833
Free Cash Flow Per Share-0.074-0.0735-0.88720.90430.0325-0.5852